Alnylam Pharmaceuticals has put its dancing shoes on to raise awareness of the experience of living with acute hepatic porphyria (AHP). A recently released patient storytelling initiative by the ...

Appeals court affirmed that SM-102 does not infringe Alnylam’s mRNA patents. The decision supports Moderna’s use of SM-102 in its Spikevax COVID-19 vaccine. Live on Wednesday June 18: 3 Summer ...

The Cambridge drugmaker was a founding member of the nonprofit OUTbio in 2015 and has also had an affinity group called the Sexuality And Gender Alliance since 2018. Mass. companies display their ...

CAMBRIDGE, Mass., May 28, 2025--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company ...

The court held that Alnylam had acted as its own lexicographer in defining the term “branched alkyl” in its patent specifications and that definition foreclosed Alnylam’s infringement ...

Alnylam Pharmaceuticals specializes in the development and commercialization of RNAi therapeutics for genetically defined diseases. The company has established itself as a leader in this ...

EXCLUSIVE: Martin Scorsese, Leonardo DiCaprio, Chad A. Verdi, LBI Entertainment’s Christopher Donelly and Gareth West have teamed to produce Carthage Must Be Destroyed, an action to be directed ...

Tyler O'Neil is senior editor at The Daily Signal and the author of two books: "Making Hate Pay: The Corruption of the Southern Poverty Law Center," and "The Woketopus: The Dark Money Cabal ...

It was mid-April, and Ed Martin knew his nomination was in danger. The interim U.S. attorney for the District of Columbia had been in the job for about three months. But a cascade of revelations ...

By Lily Ford George R. R. Martin has signed on with Lion Forge Entertainment to adapt Howard Waldrop’s A Dozen Tough Jobs into an adult animated feature film, The Hollywood Reporter can ...

On June 2, H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his price target from $400 to $500. His bullish view reflects ...